Loading…
Session Description
In this session we will gain an insider’s perspective on the investment priorities and focus areas of health and biotech VCs, based on their privileged view of multiple market forces, sector trends and the massive opportunities of the latest technological and scientific developments, such as AI, personalised medicine, genomics, advanced therapies, cost-effective technology solutions that enhance patient care, etc.